论文部分内容阅读
487例中晚期贲门癌3、5及10年存活率分别为33.2、19.24及8.48％。引流区淋巴滤泡、淋巴细胞增生型比无改变及衰竭型预后明显好,癌周有淋巴细胞反应、纤维包裹的比无反应、无包裹的好。淋巴窦组织细胞增生阴、阳性与预后无明显差异。同一组织学类型伴二、三项免疫指标或癌周反应阳性者预后明显比一项者好。宿主反应阳性的比例随分化程度而增高,它对预后的影响也随分化程度而异。组织学类型仍是决定预后的基本因素。
The survival rates of 487 patients with advanced cardiac cancer at 3, 5, and 10 years were 33.2, 19.24, and 8.48%, respectively. The prognosis of lymphoid follicles and lymphoproliferation type in the drainage area was significantly better than that in the undifferentiated and depleted type. Lymphocytic reaction, fiber-wrapped tumors were better than non-responders, and had no parcels. Lymphatic sinusoidal cell proliferation, positivity and prognosis were not significantly different. Patients with the same histological type with two or three immune markers or positive cancer-positive patients had significantly better prognosis than those with one. The proportion of positive host reactions increases with the degree of differentiation, and its effect on prognosis also varies with the degree of differentiation. The type of histology is still the basic factor that determines the prognosis.